טוען...
The Use of Genomics to Drive Kidney Disease Drug Discovery and Development
As opposed to diseases such as cancer, autoimmune disease, and diabetes, identifying drugs to treat CKD has proven significantly more challenging. Over the past 2 decades, new potential therapeutic targets have been identified as genetically altered proteins involved in rare monogenetic kidney disea...
שמור ב:
| הוצא לאור ב: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480559/ https://ncbi.nlm.nih.gov/pubmed/32193173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11070919 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|